Streetbeat News

Regulatory

AAPL

GOOG

PYPL

The Consumer Financial Protection Bureau (CFPB) has proposed a rule that would subject large nonbank consumer payment companies, including Apple Inc., Alphabet Inc., and PayPal Holdings Inc., to regular federal examinations. The move aims to ensure these companies comply with laws relating to unfair or deceptive practices and data privacy protections. The proposed rule targets companies that process over 5 million transactions annually.

Portfolio Pulse from Benzinga Neuro

November 08, 2023 | 3:57 am

CMCSA

RUM

Despite ongoing legal challenges, former President Donald Trump continues to lead the field of Republican candidates for the 2024 presidential election, according to a Morning Consult poll. Trump's support among GOP voters has reached 63%, a new high since polling began in December. The third Republican debate, scheduled for Nov. 8, will be broadcast by Comcast Corporation (NASDAQ:CMCSA) and streamed by Rumble Inc (NASDAQ:RUM). Trump will not be participating in the debate.

Portfolio Pulse from Chris Katje

November 07, 2023 | 11:18 pm

HTOO

Fusion Fuel Green Plc (NASDAQ:HTOO) has received a notice from Nasdaq for not meeting the $1.00 minimum bid price requirement for continued listing. The company has until May 6, 2024, to regain compliance by having the closing bid price of its shares meet or exceed $1.00 for at least ten consecutive business days. The company's shares continue to trade on The Nasdaq Global Market under the symbol 'HTOO'.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 10:46 pm

AMZN

TSLA

China's Ministry of Industry and Information Technology has published a blueprint document outlining plans to mass-produce humanoid robots by 2025. The country aims to support robotics startups and develop talent in the field. The government is encouraging the use of AI in the robots, with a focus on making robot limbs more dexterous and developing humanoid bots that can think, learn, and innovate independently. Tesla and Amazon are among the companies mentioned that are also developing humanoid robots.

Portfolio Pulse from Adam Eckert

November 07, 2023 | 10:43 pm

OGN

Samsung Bioepis and Organon & Co. (NYSE:OGN) have announced that the FDA has accepted for review the Supplemental Biologics License Application (sBLA) for the interchangeability designation for HADLIMA, a biosimilar to Humira. The sBLA was submitted based on clinical data from a Phase 4 study assessing the pharmacokinetic similarity between two treatment groups. The acceptance of the filing reinforces the commitment of both companies to provide better access to biologic medicines for patients in the United States.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 10:38 pm

HLGN

Heliogen has announced the suspension of its NYSE listing status, with shares halted ahead of the announcement.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 10:36 pm

KRMD

KORU Medical Systems, Inc. (NASDAQ:KRMD) has received FDA clearance for the use of the FREEDOM60 Infusion System with Hizentra 50 mL prefilled syringes. This makes it the first and only FDA-cleared infusion system for use with prefilled syringes. The system is expected to significantly improve the ease of use for patients self-administering subcutaneous immunoglobulin therapy at home.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 10:14 pm

COIN

Kazakhstan's authorities have blocked the website of Coinbase (NASDAQ:COIN), the world's second-largest crypto exchange, due to violations of the country's Digital Assets Law. The block is a response to Coinbase's operations, which are said to contradict the nation's laws on digital assets. This comes as the digital asset sector continues to grapple with regulatory frameworks worldwide.

Portfolio Pulse from Murtuza Merchant

November 07, 2023 | 10:13 pm

LUMO

Lumos Pharma, Inc. (NASDAQ:LUMO) announced that its Phase 2 OraGrowtH210 and OraGrowtH212 trials of LUM-201 in pediatric growth hormone deficiency (PGHD) met all primary and secondary endpoints. The trials demonstrated that LUM-201 can enhance annualized height velocities (AHVs) in line with established standards for moderate PGHD patients undergoing recombinant growth hormone (rhGH) therapy. The company plans to discuss these data and finalize plans for a Phase 3 pivotal trial with the FDA in the first half of 2024.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 10:05 pm

MFIC

Trading of MidCap Financial Investment Corp (MFIC) shares has been halted due to pending news.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 8:03 pm